Md Sahab Uddin

InstitutionSoutheast University
AddressDhaka
Bangladesh
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 31 publications over 4 distinct years, with a maximum of 17 publications in 2019
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rahman MM, Ahmed M, Islam MT, Khan MR, Sultana S, Maeesa SK, Hasan S, Hossain MA, Ferdous KS, Mathew B, Rauf A, Uddin MS. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19 Curr Pharm Des. 2021 07 01. PMID: 34218774.
      Citations:    Fields:    
    2. Singh R, Singh PK, Kumar R, Kabir MT, Kamal MA, Rauf A, Albadrani GM, Sayed AA, Mousa SA, Abdel-Daim MM, Uddin MS. Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19. Front Pharmacol. 2021; 12:652335. PMID: 34054532.
      Citations: 2     
    3. Behl T, Rocchetti G, Chadha S, Zengin G, Bungau S, Kumar A, Mehta V, Uddin MS, Khullar G, Setia D, Arora S, Sinan KI, Ak G, Putnik P, Gallo M, Montesano D. Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview. Pharmaceuticals (Basel). 2021 Apr 19; 14(4). PMID: 33921724.
      Citations: 4     
    4. Kumar R, Sharma A, Srivastava JK, Siddiqui MH, Uddin MS, Aleya L. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications. Environ Sci Pollut Res Int. 2021 Aug; 28(30):40431-40444. PMID: 33447984.
      Citations: 5     Fields:    Translation:Humans
    5. Hasana S, Hossain MF, Jalouli M, Kabir MT, Uddin MG, Wahed MII, Behl T, Bin-Jumah MN, Abdel-Daim MM, Aleya L, Uddin MS. Genetic Diversity of SARS-CoV2 and Environmental Settings: Possible Association with Neurological Disorders. Mol Neurobiol. 2021 May; 58(5):1917-1931. PMID: 33404977.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. Shahriar S, Rana MS, Hossain MS, Karim A, Mredula TN, Nourin N, Uddin MS, Amran MS. COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact. Curr Pharm Des. 2021; 27(33):3502-3525. PMID: 33655825.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    7. Hossain MF, Hasana S, Mamun AA, Uddin MS, Wahed MII, Sarker S, Behl T, Ullah I, Begum Y, Bulbul IJ, Amran MS, Rahman MH, Bin-Jumah MN, Alkahtani S, Mousa SA, Aleya L, Abdel-Daim MM. COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management. Front Pharmacol. 2020; 11:563478. PMID: 33178016.
      Citations: 13     
    8. Kumar R, Srivastava JK, Singh R, Siddiqui MH, Mansouri RA, Abdulhakim JA, Bin-Jumah MN, Alkahtani S, Abdel-Daim MM, Uddin MS. Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines. Front Pharmacol. 2020; 11:582025. PMID: 33123014.
      Citations: 3     
    9. Behl T, Kaur I, Bungau S, Kumar A, Uddin MS, Kumar C, Pal G, Shrivastava K, Zengin G, Arora S. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions. Life Sci. 2020 Sep 15; 257:118075. PMID: 32653522.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
    10. Kabir MT, Uddin MS, Hossain MF, Abdulhakim JA, Alam MA, Ashraf GM, Bungau SG, Bin-Jumah MN, Abdel-Daim MM, Aleya L. nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. Front Cell Dev Biol. 2020; 8:616. PMID: 32754599.
      Citations: 19